Insider: Murugan Amar EVP, Chief Legal Officer - Atara Biotherapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 27,108 | 0 | 27,108 |
| Value | $364,873.68 | $0.00 | $364,873.68 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/16/2024 | DDS | 877 | Direct | COM | $6.63 | $5,813.63 | 27,108 |
| 08/16/2024 | DDS | 192 | Direct | COM | $6.63 | $1,272.96 | 26,916 |
| 08/16/2024 | DDS | 89 | Direct | COM | $6.63 | $590.16 | 26,827 |
| 05/16/2024 | DDS | 32,401 | Direct | COM | $0.62 | $19,991.42 | 695,120 |
| 03/04/2024 | DDS | 10,044 | Direct | COM | $0.72 | $7,231.68 | 727,521 |
| 11/16/2023 | DDS | 8,307 | Direct | COM | $0.39 | $3,231.42 | 257,084 |
| 08/16/2023 | DDS | 5,050 | Direct | COM | $1.65 | $8,342.60 | 269,013 |
| 08/16/2023 | DDS | 3,622 | Direct | COM | $1.65 | $5,987.17 | 265,391 |
| 05/16/2023 | DDS | 7,404 | Direct | COM | $2.04 | $15,081.95 | 271,930 |
| 05/16/2023 | DDS | 985 | Direct | COM | $2.04 | $2,007.43 | 270,945 |
| 03/02/2023 | DDS | 4,221 | Direct | COM | $3.63 | $15,309.57 | 279,334 |
| 11/16/2022 | DDS | 3,612 | Direct | COM | $4.49 | $16,217.88 | 127,586 |
| 08/16/2022 | DDS | 1,196 | Direct | COM | $5.03 | $6,020.66 | 133,432 |
| 08/16/2022 | DDS | 2,234 | Direct | COM | $5.04 | $11,248.19 | 131,198 |
| 05/17/2022 | DDS | 2,317 | Direct | COM | $5.32 | $12,317.17 | 134,641 |
| 05/17/2022 | DDS | 906 | Direct | COM | $5.32 | $4,817.20 | 133,735 |
| 03/01/2022 | DDS | 1,465 | Direct | COM | $9.86 | $14,440.51 | 138,070 |
| 03/01/2022 | DDS | 1,112 | Direct | COM | $9.86 | $10,959.87 | 136,958 |
| 11/16/2021 | DDS | 2,124 | Direct | COM | $17.12 | $36,356.30 | 87,540 |
| 08/17/2021 | DDS | 2,080 | Direct | COM | $12.53 | $26,066.56 | 89,664 |
| 05/18/2021 | DDS | 5,681 | Direct | COM | $14.55 | $82,658.55 | 91,744 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research